Webinars
Medication Management of Elective First Trimester Abortion
Archived Sessions:
This is an internet-based activity that should take 1 hour to complete.
To participate in this archived webinar learners should:
- Take the pretest
- Listen to webinar
- Take the post-test
- Complete follow-up evaluation survey
Learning Objectives
At the conclusion of this presentation, participants should be able to:
- Identify at least three advantages of using medication management for elective first trimester abortion
- Implement at least one medication regimen used for elective first trimester abortion
- Recognize at least four factors to consider when counseling women about using medication management for elective first trimester abortion
- Screen patients for contraindications to medication management of elective first trimester abortion
Accreditation Information
Physicians:
ACCREDITATION The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses:
This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Others:
A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.
Sponsoring Information
This program is sponsored by the Association of Reproductive Health Professionals.
Funding Information
This project is funded through an educational grant from Danco Laboratories, LLC.
Disclosure Information
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Advisory Committee Disclosures
|
Mary Fjerstad, RN, BSN, MHS, NP
Nurse Practitioner Planned Parenthood of San Diego and Riverside Counties
Ms. Fjerstad has no affiliations to disclose.
Allison A. Cowett, MD MPH
Clinical Assistant Professor of Obstetrics and Gynecology University of Illinois at Chicago (UIC)
Dr. Cowett has no affiliations to disclose. |
Emily Godfrey, MD, MPH
Guest Researcher Women's Health and Fertility Branch Division of Reproductive Health Centers for Disease Control and Prevention
Dr. Godfrey s a speaker for Merck & Co. Inc. and an Implanon Trainer for Schering-Plough |
ARHP Staff/Consultant Disclosures
|
Ellen Cohen, Cert Ed, Dip Ed
Director of Education
Nothing to disclose
Camille Harris, MPH
Program Manager
Nothing to disclose
Alexandra Howson, MD
Consultant (Expert Medical Writer)
Nothing to disclose |
Beth Jordan, MD
Medical Director
Nothing to disclose
Amy Swann, MA, CAE
Vice President of Operations
Nothing to disclose
Wayne Shields
President and CEO
Nothing to disclose |
Back
|